These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 3106703)

  • 1. [Treatment of Pseudomonas aeruginosa infection in burn patients].
    Litovchenko PP; Nazarchuk LV; Degtiar NV; Abu-el-Khava MI; Gaĭduk VI
    Klin Khir (1962); 1987; (3):24-7. PubMed ID: 3106703
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug sensitivity of Pseudomonas aeruginosa isolated from burn wounds during 1985/1986 and its serologic types].
    Ziółkowski G; Dudzińska G; Sakiel S
    Pol Tyg Lek; 1988 Dec; 43(49):1596-8. PubMed ID: 3151376
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Pseudomonas aeruginosa isolates from burn patients in the Northwest of Pakistan.
    Arya SC; Agarwal N; Agarwal S
    Burns; 2010 Aug; 36(5):739-40. PubMed ID: 20071094
    [No Abstract]   [Full Text] [Related]  

  • 4. The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns.
    Cooper RA; Halas E; Molan PC
    J Burn Care Rehabil; 2002; 23(6):366-70. PubMed ID: 12432313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ways of increasing the effectiveness of antibacterial drugs in the treatment of pseudomonas infection in burns].
    Moroz AF; Vinogradova OI; Bekbergenov BM; Brodinova NS; Antsiferova NG
    Khirurgiia (Mosk); 1976 Jun; (6):81-8. PubMed ID: 827653
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
    Naqvi SH; Naqvi SH
    S Afr J Surg; 2013 Oct; 51(4):151-2. PubMed ID: 24209702
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
    Coetzee E; Rode H; Kahn D
    S Afr J Surg; 2013 May; 51(2):50-3. PubMed ID: 23725892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model.
    Barnea Y; Carmeli Y; Neville LF; Kahel-Reifer H; Eren R; Dagan S; Navon-Venezia S
    Burns; 2009 May; 35(3):390-6. PubMed ID: 18951715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine Is a Critical Substrate for the Pathogenesis of
    Everett J; Turner K; Cai Q; Gordon V; Whiteley M; Rumbaugh K
    mBio; 2017 Mar; 8(2):. PubMed ID: 28292986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas infections in Tohid Burn Center, Iran.
    Rastegar Lari A; Bahrami Honar H; Alaghehbandan R
    Burns; 1998 Nov; 24(7):637-41. PubMed ID: 9882062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection in burns.
    Settle JA
    J Hosp Infect; 1985 Sep; 6 Suppl B():19-29. PubMed ID: 2865307
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis.
    Glik J; Kawecki M; Gaździk T; Nowak M
    Pol Przegl Chir; 2012 Jan; 84(1):6-16. PubMed ID: 22472489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An experimental validation of the use of levomycetin preparations for the treatment of burns infected with Pseudomonas aeruginosa].
    Tkachenko VL; Tsyganenko AIa; Liapunov NA; Bezuglaia EP; Minukhin VV
    Mikrobiol Z; 1999; 61(3):30-6. PubMed ID: 10483230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal activity of different types of honey against clinical and environmental isolates of Pseudomonas aeruginosa.
    Mullai V; Menon T
    J Altern Complement Med; 2007 May; 13(4):439-41. PubMed ID: 17532737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Mannosidase and Trypsin Enzymes Effects on Biofilm Production of Pseudomonas aeruginosa Isolated from Burn Wound Infections.
    Banar M; Emaneini M; Satarzadeh M; Abdellahi N; Beigverdi R; Leeuwen WB; Jabalameli F
    PLoS One; 2016; 11(10):e0164622. PubMed ID: 27736961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental efficacy of apalcillin and cefpiramide compared with that of six other antipseudomonal agents in Pseudomonas aeruginosa burn infections.
    Fu KP; Vince T; Hung PP; Gregory JF
    Drugs Exp Clin Res; 1986; 12(4):303-6. PubMed ID: 3720518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
    Faezi S; Sattari M; Mahdavi M; Roudkenar MH
    Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microbiological analysis of experimental burn wounds in swine during treatment with silver sulfadiazine].
    Denys A; Grzybowski A; Białek J; Horoszewicz-Małafiej A; Korczak E; Kowalska M; Małafiej E; Szydłowska T
    Med Dosw Mikrobiol; 1983; 35(2):155-62. PubMed ID: 6423917
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudomonas aeruginosa bacteraemia in burns patients: Risk factors and outcomes.
    Mahar P; Padiglione AA; Cleland H; Paul E; Hinrichs M; Wasiak J
    Burns; 2010 Dec; 36(8):1228-33. PubMed ID: 20965109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental burn wound sepsis: variations in response to topical agents.
    Krizek TJ; Cossman DV
    J Trauma; 1972 Jul; 12(7):553-62. PubMed ID: 4625533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.